Gilbert, Jennifer L. and Purcell, James and Strappe, Padraig and McCabe, Matthew and O'Brien, Timothy and O'Dea, Shirley (2008) Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells. Anti-Cancer Drugs, 19. pp. 783-788. ISSN 0959-4973
Download (114kB)
|
Abstract
Few studies have directly compared the efficiencies of gene delivery methods that target normal lung cells versus lung tumor cells. We report the first study directly comparing the efficiency and toxicity of viral [adenoassociated virus (AAV2, 5, 6) and lentivirus], nonviral (Effectene, SuperFect and Lipofectamine 2000) and physical [particle-mediated gene transfer (PMGT)] methods of gene delivery in normal mouse lung cells and in mouse adenocarcinoma cells. Lentivirus pseudotyped with the vesicular stomatitis virus glycoprotein was the most efficient gene transfer method for normal mouse airway epithelial cells [25.95 ( ± 3.57) %] whereas AAV6 was most efficient for MLE-12 adenocarcinoma cells [68.2 (± 3.2) %]. PMGT was more efficient in normal mouse airway epithelial cells than AAV5, Lipofectamine 2000 and SuperFect. AAV5 displayed the lowest transfection efficiency at less than 10% in both cell types. PMGT was the only method that resulted in significant toxicity. In summary, for all of the gene delivery methods examined here, lung tumor cells were transfected more easily than normal lung cells. Lipofectamine 2000 is potentially highly selective for lung tumor cells whereas AAV6 and lentivirus vesicular stomatitis virus glycoprotein may be useful for gene delivery strategies that require targeting of both normal and tumor cells
Item Type: | Article |
---|---|
Keywords: | adeno-associated virus; lipofection; lung cancer; particle bombardment; non-viral; |
Academic Unit: | Faculty of Science and Engineering > Research Institutes > Institute of Immunology |
Item ID: | 2829 |
Depositing User: | Dr. Shirley O'Dea |
Date Deposited: | 15 Nov 2011 12:22 |
Journal or Publication Title: | Anti-Cancer Drugs |
Publisher: | Lippincott, Williams & Wilkins |
Refereed: | Yes |
URI: | |
Use Licence: | This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here |
Repository Staff Only(login required)
Item control page |
Downloads
Downloads per month over past year